Underlying inflammation in patients with severe/ uncontrolled CRSwNP: from targeting type 2 pathophysiology to shared clinical decision-making
v/ Prof. Gevaert og MD Toppila-Salmi
Mød professor Gevaert og professor Toppila-Salmi i dette webinar.
På mødet vil der blive diskuteret påvirkningen af type 2-inflammation hos patienter med ukontrolleret CRSwNP, samt de kliniske erfaringer ved brug af biologisk medicin til denne gruppe patienter.
Tirsdag den 24. oktober 2023
Speakers
Professor Philippe Gevaert
Philippe Gevaert, MD, Ph.D., is full professor in Rhinology and Allergy at the Department of Otorhinolaryngology and Chairman medical education at the Ghent University, Belgium. Further, he is the scientific coordinator of the Allergy Network of the Ghent University Hospital. Since 1998 he is active in the Upper Airway Research Laboratory at the University of Ghent. He is the past Chairman of the ENT section of the EAACI. Currently, his research is focused on local IgE, allergen specific immunotherapy and biologicals in allergic rhinitis and nasal polyps. He has conducted several academic and industry sponsored clinical trials with novel treatments in nasal polyps and allergic rhinitis. He has published over 200 peer-reviewed papers.
Professor Sanna Toppila-Salmi
Sanna Toppila-Salmi, MD, PhD, Adj. Prof. is a Senior Consultant Otorhinolaryngologist, Department Chief Physician and Director of Helsinki Airway Research Group at the Skin and Allergy Hospital of the Helsinki University Hospital & University of Helinski and Professor at the University of Eastern Finland. Her research group combines epidemiology, genomics, metabolomics and sequence analysis to identify the pathobiology of NERD, type 2 inflammation, CRSwNP, asthma and allergic diseases. Her lab works with human cohorts to identify risk factors, mechanisms, and potential therapies for these disorders using machinge learning data science, sequencing omics approaches and clinical trials.
Dette webinar er forbehold sundhedsfaglige personer og bliver afholdt af Sanofi North Europe. Arrangementet er anmeldt til ENLI (Etisk Nævn for Lægemiddelindustrien) inden arrangementets afholdelse, og arrangementet er efter Sanofi’s opfattelse i overensstemmelse med området, selv om arrangementet ikke på forhånd er godkendt af ENLI.
For at læse denne side skal du være logget ind. Hvis du ikke har en konto, kan du oprette en her.
Dette kunne også være af interesse
Polyp Gossip - latest episode
Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences. Each episode features esteemed guests, including experts and patients, offering valuable insights into the evolving world of CRSwNP.
Polyp Gossip Episode 7: Unified Airways: Bridging Type 2 and Comorbidities in CRSwNP
What links CRSwNP, asthma, and other comorbidities? In this episode, our experts unpack the unified airways concept and why it’s key to understanding Type 2 inflammation and optimizing patient care. Our experts discuss integrated care approaches and what they mean for clinical practice.
Polyp Gossip Episode 6: Multidisciplinary approach in management of CRSwNP
In this episode of Polyp Gossip, we explore the importance of a multidisciplinary approach in managing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Join leading experts from rhinology and pulmonology as they discuss how collaboration across specialties can improve patient outcomes and optimize care pathways.